Metraipolis › archive › dc_1bf083d39472
A flexible dose-response modeling framework based on continuous toxicity outcomes in phase I cancer clinical trials — Europe PMC PMID:37990281
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/37990281
- DOI
- 10.1186/s13063-[numero omesso]-0
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T13:06:20.831Z
- SHA-256 of the archived text
08b8445417f8b608127c5b39666b1f408b3f19809f823e7f89bf9c61926e08db- Stable URL of this page
https://metraipolis.com/documento/dc_1bf083d39472
How to cite
A flexible dose-response modeling framework based on continuous toxicity outcomes in phase I cancer clinical trials — Europe PMC PMID:37990281 — Europe PMC (en), https://europepmc.org/article/MED/37990281 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1bf083d39472 (Metraipolis archive dc_1bf083d39472, sha256 08b8445417f8b608127c5b39666b1f408b3f19809f823e7f89bf9c61926e08db)
BibTeX
@misc{dc1bf083d39472,
title = {A flexible dose-response modeling framework based on continuous toxicity outcomes in phase I cancer clinical trials — Europe PMC PMID:37990281},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/37990281},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1bf083d39472; sha256 08b8445417f8b608127c5b39666b1f408b3f19809f823e7f89bf9c61926e08db},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37990281. Agents can read the archived copy with the MCP tool read_document.